Global Vaccine Adjuvants Market Research Report 2020

Publisher Name :
Date: 03-Jan-2020
No. of pages: 124
Inquire Before Buying

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

The classification of vaccine adjuvants includes veterinary vaccine adjuvants and human vaccine adjuvants. And the proportion of human vaccine adjuvants in 2016 is about 52.4%. The veterinary vaccine adjuvants in 2015 are about 47.6%.

The classification of Veterinary Vaccine Adjuvants includes Oral, Subcutaneous, Intramuscular and Others. And the proportion of Intramuscular in 2016 is about 56.3%. The Subcutaneous in 2016 is about 29%.

The classification of Human Vaccine Adjuvants includes Oral, Subcutaneous, Intramuscular and Others. And the proportion of Intramuscular in 2016 is about 55.5%. The Subcutaneous in 2016 is about 28.8%.

The global Vaccine Adjuvants market is valued at 686.4 million US$ in 2020 is expected to reach 1364.7 million US$ by the end of 2026, growing at a CAGR of 10.2% during 2021-2026.

This report focuses on Vaccine Adjuvants volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Vaccine Adjuvants market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.

Market Segment Analysis

The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Vaccine Adjuvants market is segmented into

- Oral

- Subcutaneous

- Intramuscular

- Others

Segment by Application

- Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)

- Human Vaccine Adjuvants (Research Applications, Commercial Applications)

Global Vaccine Adjuvants Market: Regional Analysis

The Vaccine Adjuvants market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Vaccine Adjuvants market report are:

North America

- U.S.

- Canada

Europe

- Germany

- France

- U.K.

- Italy

- Russia

Asia-Pacific

- China

- Japan

- South Korea

- India

- Australia

- Taiwan

- Indonesia

- Thailand

- Malaysia

- Philippines

- Vietnam

Latin America

- Mexico

- Brazil

- Argentina

Middle East & Africa

- Turkey

- Saudi Arabia

- U.A.E

Global Vaccine Adjuvants Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Vaccine Adjuvants market include:

- SEPPIC

- SDA BIO

- Croda International Plc

- SPI Pharma

- Phibro Animal Health Corporation

- Tj Kaiwei

- Novavax

- Zhuoyue

- Aphios

- GSK

- CSL Limited

- Brenntag Biosector

- SEPPIC

- SPI Pharma

- Novavax

- Avanti Polar Lipids

- Aphios

Global Vaccine Adjuvants Market Research Report 2020

Table of Contents
1 Vaccine Adjuvants Market Overview
1.1 Product Overview and Scope of Vaccine Adjuvants
1.2 Vaccine Adjuvants Segment by Type
1.2.1 Global Vaccine Adjuvants Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Oral
1.2.3 Subcutaneous
1.2.4 Intramuscular
1.2.5 Others
1.3 Vaccine Adjuvants Segment by Application
1.3.1 Vaccine Adjuvants Sales Comparison by Application: 2020 VS 2026
1.3.2 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
1.3.3 Human Vaccine Adjuvants (Research Applications, Commercial Applications)
1.4 Global Vaccine Adjuvants Market Size Estimates and Forecasts
1.4.1 Global Vaccine Adjuvants Revenue 2015-2026
1.4.2 Global Vaccine Adjuvants Sales 2015-2026
1.4.3 Vaccine Adjuvants Market Size by Region: 2020 Versus 2026
2 Global Vaccine Adjuvants Market Competition by Manufacturers
2.1 Global Vaccine Adjuvants Sales Market Share by Manufacturers (2015-2020)
2.2 Global Vaccine Adjuvants Revenue Share by Manufacturers (2015-2020)
2.3 Global Vaccine Adjuvants Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Vaccine Adjuvants Manufacturing Sites, Area Served, Product Type
2.5 Vaccine Adjuvants Market Competitive Situation and Trends
2.5.1 Vaccine Adjuvants Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Vaccine Adjuvants Players (Opinion Leaders)
3 Vaccine Adjuvants Retrospective Market Scenario by Region
3.1 Global Vaccine Adjuvants Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Vaccine Adjuvants Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Vaccine Adjuvants Market Facts & Figures by Country
3.3.1 North America Vaccine Adjuvants Sales by Country
3.3.2 North America Vaccine Adjuvants Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Vaccine Adjuvants Market Facts & Figures by Country
3.4.1 Europe Vaccine Adjuvants Sales by Country
3.4.2 Europe Vaccine Adjuvants Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Vaccine Adjuvants Market Facts & Figures by Region
3.5.1 Asia Pacific Vaccine Adjuvants Sales by Region
3.5.2 Asia Pacific Vaccine Adjuvants Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Vaccine Adjuvants Market Facts & Figures by Country
3.6.1 Latin America Vaccine Adjuvants Sales by Country
3.6.2 Latin America Vaccine Adjuvants Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Vaccine Adjuvants Market Facts & Figures by Country
3.7.1 Middle East and Africa Vaccine Adjuvants Sales by Country
3.7.2 Middle East and Africa Vaccine Adjuvants Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Vaccine Adjuvants Historic Market Analysis by Type
4.1 Global Vaccine Adjuvants Sales Market Share by Type (2015-2020)
4.2 Global Vaccine Adjuvants Revenue Market Share by Type (2015-2020)
4.3 Global Vaccine Adjuvants Price Market Share by Type (2015-2020)
4.4 Global Vaccine Adjuvants Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Vaccine Adjuvants Historic Market Analysis by Application
5.1 Global Vaccine Adjuvants Sales Market Share by Application (2015-2020)
5.2 Global Vaccine Adjuvants Revenue Market Share by Application (2015-2020)
5.3 Global Vaccine Adjuvants Price by Application (2015-2020)
6 Company Profiles and Key Figures in Vaccine Adjuvants Business
6.1 SEPPIC
6.1.1 Corporation Information
6.1.2 SEPPIC Description, Business Overview and Total Revenue
6.1.3 SEPPIC Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.1.4 SEPPIC Products Offered
6.1.5 SEPPIC Recent Development
6.2 SDA BIO
6.2.1 SDA BIO Vaccine Adjuvants Production Sites and Area Served
6.2.2 SDA BIO Description, Business Overview and Total Revenue
6.2.3 SDA BIO Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.2.4 SDA BIO Products Offered
6.2.5 SDA BIO Recent Development
6.3 Croda International Plc
6.3.1 Croda International Plc Vaccine Adjuvants Production Sites and Area Served
6.3.2 Croda International Plc Description, Business Overview and Total Revenue
6.3.3 Croda International Plc Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Croda International Plc Products Offered
6.3.5 Croda International Plc Recent Development
6.4 SPI Pharma
6.4.1 SPI Pharma Vaccine Adjuvants Production Sites and Area Served
6.4.2 SPI Pharma Description, Business Overview and Total Revenue
6.4.3 SPI Pharma Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.4.4 SPI Pharma Products Offered
6.4.5 SPI Pharma Recent Development
6.5 Phibro Animal Health Corporation
6.5.1 Phibro Animal Health Corporation Vaccine Adjuvants Production Sites and Area Served
6.5.2 Phibro Animal Health Corporation Description, Business Overview and Total Revenue
6.5.3 Phibro Animal Health Corporation Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Phibro Animal Health Corporation Products Offered
6.5.5 Phibro Animal Health Corporation Recent Development
6.6 Tj Kaiwei
6.6.1 Tj Kaiwei Vaccine Adjuvants Production Sites and Area Served
6.6.2 Tj Kaiwei Description, Business Overview and Total Revenue
6.6.3 Tj Kaiwei Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Tj Kaiwei Products Offered
6.6.5 Tj Kaiwei Recent Development
6.7 Novavax
6.6.1 Novavax Vaccine Adjuvants Production Sites and Area Served
6.6.2 Novavax Description, Business Overview and Total Revenue
6.6.3 Novavax Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Novavax Products Offered
6.7.5 Novavax Recent Development
6.8 Zhuoyue
6.8.1 Zhuoyue Vaccine Adjuvants Production Sites and Area Served
6.8.2 Zhuoyue Description, Business Overview and Total Revenue
6.8.3 Zhuoyue Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Zhuoyue Products Offered
6.8.5 Zhuoyue Recent Development
6.9 Aphios
6.9.1 Aphios Vaccine Adjuvants Production Sites and Area Served
6.9.2 Aphios Description, Business Overview and Total Revenue
6.9.3 Aphios Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Aphios Products Offered
6.9.5 Aphios Recent Development
6.10 GSK
6.10.1 GSK Vaccine Adjuvants Production Sites and Area Served
6.10.2 GSK Description, Business Overview and Total Revenue
6.10.3 GSK Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.10.4 GSK Products Offered
6.10.5 GSK Recent Development
6.11 CSL Limited
6.11.1 CSL Limited Vaccine Adjuvants Production Sites and Area Served
6.11.2 CSL Limited Vaccine Adjuvants Description, Business Overview and Total Revenue
6.11.3 CSL Limited Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.11.4 CSL Limited Products Offered
6.11.5 CSL Limited Recent Development
6.12 Brenntag Biosector
6.12.1 Brenntag Biosector Vaccine Adjuvants Production Sites and Area Served
6.12.2 Brenntag Biosector Vaccine Adjuvants Description, Business Overview and Total Revenue
6.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Brenntag Biosector Products Offered
6.12.5 Brenntag Biosector Recent Development
6.13 SEPPIC
6.13.1 SEPPIC Vaccine Adjuvants Production Sites and Area Served
6.13.2 SEPPIC Vaccine Adjuvants Description, Business Overview and Total Revenue
6.13.3 SEPPIC Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.13.4 SEPPIC Products Offered
6.13.5 SEPPIC Recent Development
6.14 SPI Pharma
6.14.1 SPI Pharma Vaccine Adjuvants Production Sites and Area Served
6.14.2 SPI Pharma Vaccine Adjuvants Description, Business Overview and Total Revenue
6.14.3 SPI Pharma Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.14.4 SPI Pharma Products Offered
6.14.5 SPI Pharma Recent Development
6.15 Novavax
6.15.1 Novavax Vaccine Adjuvants Production Sites and Area Served
6.15.2 Novavax Vaccine Adjuvants Description, Business Overview and Total Revenue
6.15.3 Novavax Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Novavax Products Offered
6.15.5 Novavax Recent Development
6.16 Avanti Polar Lipids
6.16.1 Avanti Polar Lipids Vaccine Adjuvants Production Sites and Area Served
6.16.2 Avanti Polar Lipids Vaccine Adjuvants Description, Business Overview and Total Revenue
6.16.3 Avanti Polar Lipids Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Avanti Polar Lipids Products Offered
6.16.5 Avanti Polar Lipids Recent Development
6.17 Aphios
6.17.1 Aphios Vaccine Adjuvants Production Sites and Area Served
6.17.2 Aphios Vaccine Adjuvants Description, Business Overview and Total Revenue
6.17.3 Aphios Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Aphios Products Offered
6.17.5 Aphios Recent Development
7 Vaccine Adjuvants Manufacturing Cost Analysis
7.1 Vaccine Adjuvants Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Vaccine Adjuvants
7.4 Vaccine Adjuvants Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Vaccine Adjuvants Distributors List
8.3 Vaccine Adjuvants Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Vaccine Adjuvants Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Vaccine Adjuvants by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Vaccine Adjuvants by Type (2021-2026)
10.2 Vaccine Adjuvants Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Vaccine Adjuvants by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Vaccine Adjuvants by Application (2021-2026)
10.3 Vaccine Adjuvants Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Vaccine Adjuvants by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Vaccine Adjuvants by Region (2021-2026)
10.4 North America Vaccine Adjuvants Estimates and Projections (2021-2026)
10.5 Europe Vaccine Adjuvants Estimates and Projections (2021-2026)
10.6 Asia Pacific Vaccine Adjuvants Estimates and Projections (2021-2026)
10.7 Latin America Vaccine Adjuvants Estimates and Projections (2021-2026)
10.8 Middle East and Africa Vaccine Adjuvants Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Vaccine Adjuvants Sales (Kg) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Vaccine Adjuvants Sales (Kg) Comparison by Application: 2020 VS 2026
Table 3. Global Vaccine Adjuvants Market Size by Type (Kg) (US$ Million) (2020 VS 2026)
Table 4. Global Key Vaccine Adjuvants Manufacturers Covered in This Study
Table 5. Global Vaccine Adjuvants Sales (Kg) by Manufacturers (2015-2020)
Table 6. Global Vaccine Adjuvants Sales Share by Manufacturers (2015-2020)
Table 7. Global Vaccine Adjuvants Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Vaccine Adjuvants Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Vaccine Adjuvants Average Price (USD/Kg) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Vaccine Adjuvants Sales Sites and Area Served
Table 11. Manufacturers Vaccine Adjuvants Product Types
Table 12. Global Vaccine Adjuvants Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Vaccine Adjuvants by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccine Adjuvants as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Vaccine Adjuvants Players
Table 16. Global Vaccine Adjuvants Sales (Kg) by Region (2015-2020)
Table 17. Global Vaccine Adjuvants Sales Market Share by Region (2015-2020)
Table 18. Global Vaccine Adjuvants Revenue (Million US$) by Region (2015-2020)
Table 19. Global Vaccine Adjuvants Revenue Market Share by Region (2015-2020)
Table 20. North America Vaccine Adjuvants Sales by Country (2015-2020) (Kg)
Table 21. North America Vaccine Adjuvants Sales Market Share by Country (2015-2020)
Table 22. North America Vaccine Adjuvants Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Vaccine Adjuvants Revenue Market Share by Country (2015-2020)
Table 24. Europe Vaccine Adjuvants Sales by Country (2015-2020) (Kg)
Table 25. Europe Vaccine Adjuvants Sales Market Share by Country (2015-2020)
Table 26. Europe Vaccine Adjuvants Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Vaccine Adjuvants Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Vaccine Adjuvants Sales by Region (2015-2020) (Kg)
Table 29. Asia Pacific Vaccine Adjuvants Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Vaccine Adjuvants Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Vaccine Adjuvants Revenue Market Share by Region (2015-2020)
Table 32. Latin America Vaccine Adjuvants Sales by Country (2015-2020) (Kg)
Table 33. Latin America Vaccine Adjuvants Sales Market Share by Country (2015-2020)
Table 34. Latin America Vaccine Adjuvants Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Vaccine Adjuvants Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Vaccine Adjuvants Sales by Country (2015-2020) (Kg)
Table 37. Middle East and Africa Vaccine Adjuvants Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Vaccine Adjuvants Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Vaccine Adjuvants Revenue Market Share by Country (2015-2020)
Table 40. Global Vaccine Adjuvants Sales (Kg) by Type (2015-2020)
Table 41. Global Vaccine Adjuvants Sales Share by Type (2015-2020)
Table 42. Global Vaccine Adjuvants Revenue (Million US$) by Type (2015-2020)
Table 43. Global Vaccine Adjuvants Revenue Share by Type (2015-2020)
Table 44. Global Vaccine Adjuvants Price (USD/Kg) by Type (2015-2020)
Table 45. Global Vaccine Adjuvants Sales (Kg) by Application (2015-2020)
Table 46. Global Vaccine Adjuvants Sales Market Share by Application (2015-2020)
Table 47. Global Vaccine Adjuvants Sales Growth Rate by Application (2015-2020)
Table 48. SEPPIC Vaccine Adjuvants Corporation Information
Table 49. SEPPIC Description and Business Overview
Table 50. SEPPIC Vaccine Adjuvants Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 51. SEPPIC Main Product
Table 52. SEPPIC Recent Development
Table 53. SDA BIO Vaccine Adjuvants Corporation Information
Table 54. SDA BIO Corporation Information
Table 55. SDA BIO Vaccine Adjuvants Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 56. SDA BIO Main Product
Table 57. SDA BIO Recent Development
Table 58. Croda International Plc Vaccine Adjuvants Corporation Information
Table 59. Croda International Plc Corporation Information
Table 60. Croda International Plc Vaccine Adjuvants Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 61. Croda International Plc Main Product
Table 62. Croda International Plc Recent Development
Table 63. SPI Pharma Vaccine Adjuvants Corporation Information
Table 64. SPI Pharma Corporation Information
Table 65. SPI Pharma Vaccine Adjuvants Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 66. SPI Pharma Main Product
Table 67. SPI Pharma Recent Development
Table 68. Phibro Animal Health Corporation Vaccine Adjuvants Corporation Information
Table 69. Phibro Animal Health Corporation Corporation Information
Table 70. Phibro Animal Health Corporation Vaccine Adjuvants Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 71. Phibro Animal Health Corporation Main Product
Table 72. Phibro Animal Health Corporation Recent Development
Table 73. Tj Kaiwei Vaccine Adjuvants Corporation Information
Table 74. Tj Kaiwei Corporation Information
Table 75. Tj Kaiwei Vaccine Adjuvants Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 76. Tj Kaiwei Main Product
Table 77. Tj Kaiwei Recent Development
Table 78. Novavax Vaccine Adjuvants Corporation Information
Table 79. Novavax Corporation Information
Table 80. Novavax Vaccine Adjuvants Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 81. Novavax Main Product
Table 82. Novavax Recent Development
Table 83. Zhuoyue Vaccine Adjuvants Corporation Information
Table 84. Zhuoyue Corporation Information
Table 85. Zhuoyue Vaccine Adjuvants Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 86. Zhuoyue Main Product
Table 87. Zhuoyue Recent Development
Table 88. Aphios Vaccine Adjuvants Corporation Information
Table 89. Aphios Corporation Information
Table 90. Aphios Vaccine Adjuvants Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 91. Aphios Main Product
Table 92. Aphios Recent Development
Table 93. GSK Vaccine Adjuvants Corporation Information
Table 94. GSK Corporation Information
Table 95. GSK Vaccine Adjuvants Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 96. GSK Main Product
Table 97. GSK Recent Development
Table 98. CSL Limited Vaccine Adjuvants Corporation Information
Table 99. CSL Limited Corporation Information
Table 100. CSL Limited Vaccine Adjuvants Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 101. CSL Limited Main Product
Table 102. CSL Limited Recent Development
Table 103. Brenntag Biosector Vaccine Adjuvants Corporation Information
Table 104. Brenntag Biosector Corporation Information
Table 105. Brenntag Biosector Vaccine Adjuvants Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 106. Brenntag Biosector Main Product
Table 107. Brenntag Biosector Recent Development
Table 108. SEPPIC Vaccine Adjuvants Corporation Information
Table 109. SEPPIC Corporation Information
Table 110. SEPPIC Vaccine Adjuvants Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 111. SEPPIC Main Product
Table 112. SEPPIC Recent Development
Table 113. SPI Pharma Vaccine Adjuvants Corporation Information
Table 114. SPI Pharma Corporation Information
Table 115. SPI Pharma Vaccine Adjuvants Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 116. SPI Pharma Main Product
Table 117. SPI Pharma Recent Development
Table 118. Novavax Vaccine Adjuvants Corporation Information
Table 119. Novavax Corporation Information
Table 120. Novavax Vaccine Adjuvants Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 121. Novavax Main Product
Table 122. Novavax Recent Development
Table 123. Avanti Polar Lipids Vaccine Adjuvants Corporation Information
Table 124. Avanti Polar Lipids Corporation Information
Table 125. Avanti Polar Lipids Vaccine Adjuvants Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 126. Avanti Polar Lipids Main Product
Table 127. Avanti Polar Lipids Recent Development
Table 128. Aphios Vaccine Adjuvants Corporation Information
Table 129. Aphios Corporation Information
Table 130. Aphios Vaccine Adjuvants Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 131. Aphios Main Product
Table 132. Aphios Recent Development
Table 133. Sales Base and Market Concentration Rate of Raw Material
Table 134. Key Suppliers of Raw Materials
Table 135. Vaccine Adjuvants Distributors List
Table 136. Vaccine Adjuvants Customers List
Table 137. Market Key Trends
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Global Vaccine Adjuvants Sales (Kg) Forecast by Type (2021-2026)
Table 141. Global Vaccine Adjuvants Sales Market Share Forecast by Type (2021-2026)
Table 142. Global Vaccine Adjuvants Revenue (Million US$) Forecast by Type (2021-2026)
Table 143. Global Vaccine Adjuvants Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 144. Global Vaccine Adjuvants Sales (Kg) Forecast by Application (2021-2026)
Table 145. Global Vaccine Adjuvants Revenue (Million US$) Forecast by Application (2021-2026)
Table 146. Global Vaccine Adjuvants Sales (Kg) Forecast by Region (2021-2026)
Table 147. Global Vaccine Adjuvants Sales Market Share Forecast by Region (2021-2026)
Table 148. Global Vaccine Adjuvants Revenue Forecast by Region (2021-2026) (US$ Million)
Table 149. Global Vaccine Adjuvants Revenue Market Share Forecast by Region (2021-2026)
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Vaccine Adjuvants
Figure 2. Global Vaccine Adjuvants Sales Market Share by Type: 2020 VS 2026
Figure 3. Oral Product Picture
Figure 4. Subcutaneous Product Picture
Figure 5. Intramuscular Product Picture
Figure 6. Others Product Picture
Figure 7. Global Vaccine Adjuvants Consumption Market Share by Application: 2020 VS 2026
Figure 8. Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
Figure 9. Human Vaccine Adjuvants (Research Applications, Commercial Applications)
Figure 10. Global Vaccine Adjuvants Market Size 2015-2026 (US$ Million)
Figure 11. Global Vaccine Adjuvants Sales Capacity (Kg) (2015-2026)
Figure 12. Global Vaccine Adjuvants Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Vaccine Adjuvants Sales Share by Manufacturers in 2020
Figure 14. Global Vaccine Adjuvants Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Vaccine Adjuvants Revenue in 2019
Figure 16. Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Vaccine Adjuvants Sales Market Share by Region (2015-2020)
Figure 18. Global Vaccine Adjuvants Sales Market Share by Region in 2019
Figure 19. Global Vaccine Adjuvants Revenue Market Share by Region (2015-2020)
Figure 20. Global Vaccine Adjuvants Revenue Market Share by Region in 2019
Figure 21. North America Vaccine Adjuvants Sales Market Share by Country in 2019
Figure 22. North America Vaccine Adjuvants Revenue Market Share by Country in 2019
Figure 23. U.S. Vaccine Adjuvants Sales Growth Rate (2015-2020) (Kg)
Figure 24. U.S. Vaccine Adjuvants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Vaccine Adjuvants Sales Growth Rate (2015-2020) (Kg)
Figure 26. Canada Vaccine Adjuvants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Vaccine Adjuvants Sales Market Share by Country in 2019
Figure 28. Europe Vaccine Adjuvants Revenue Market Share by Country in 2019
Figure 29. Germany Vaccine Adjuvants Sales Growth Rate (2015-2020) (Kg)
Figure 30. Germany Vaccine Adjuvants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Vaccine Adjuvants Sales Growth Rate (2015-2020) (Kg)
Figure 32. France Vaccine Adjuvants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Vaccine Adjuvants Sales Growth Rate (2015-2020) (Kg)
Figure 34. U.K. Vaccine Adjuvants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Vaccine Adjuvants Sales Growth Rate (2015-2020) (Kg)
Figure 36. Italy Vaccine Adjuvants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Vaccine Adjuvants Sales Growth Rate (2015-2020) (Kg)
Figure 38. Russia Vaccine Adjuvants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Vaccine Adjuvants Sales Market Share by Region in 2019
Figure 40. Asia Pacific Vaccine Adjuvants Revenue Market Share by Region in 2019
Figure 41. China Vaccine Adjuvants Sales Growth Rate (2015-2020) (Kg)
Figure 42. China Vaccine Adjuvants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Vaccine Adjuvants Sales Growth Rate (2015-2020) (Kg)
Figure 44. Japan Vaccine Adjuvants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Vaccine Adjuvants Sales Growth Rate (2015-2020) (Kg)
Figure 46. South Korea Vaccine Adjuvants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Vaccine Adjuvants Sales Growth Rate (2015-2020) (Kg)
Figure 48. India Vaccine Adjuvants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Vaccine Adjuvants Sales Growth Rate (2015-2020) (Kg)
Figure 50. Australia Vaccine Adjuvants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Vaccine Adjuvants Sales Growth Rate (2015-2020) (Kg)
Figure 52. Taiwan Vaccine Adjuvants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Vaccine Adjuvants Sales Growth Rate (2015-2020) (Kg)
Figure 54. Indonesia Vaccine Adjuvants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Vaccine Adjuvants Sales Growth Rate (2015-2020) (Kg)
Figure 56. Thailand Vaccine Adjuvants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Vaccine Adjuvants Sales Growth Rate (2015-2020) (Kg)
Figure 58. Malaysia Vaccine Adjuvants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Vaccine Adjuvants Sales Growth Rate (2015-2020) (Kg)
Figure 60. Philippines Vaccine Adjuvants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Vaccine Adjuvants Sales Growth Rate (2015-2020) (Kg)
Figure 62. Vietnam Vaccine Adjuvants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Vaccine Adjuvants Sales Market Share by Country in 2019
Figure 64. Latin America Vaccine Adjuvants Revenue Market Share by Country in 2019
Figure 65. Mexico Vaccine Adjuvants Sales Growth Rate (2015-2020) (Kg)
Figure 66. Mexico Vaccine Adjuvants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil Vaccine Adjuvants Sales Growth Rate (2015-2020) (Kg)
Figure 68. Brazil Vaccine Adjuvants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina Vaccine Adjuvants Sales Growth Rate (2015-2020) (Kg)
Figure 70. Argentina Vaccine Adjuvants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa Vaccine Adjuvants Sales Market Share by Country in 2019
Figure 72. Middle East and Africa Vaccine Adjuvants Revenue Market Share by Country in 2019
Figure 73. Turkey Vaccine Adjuvants Sales Growth Rate (2015-2020) (Kg)
Figure 74. Turkey Vaccine Adjuvants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia Vaccine Adjuvants Sales Growth Rate (2015-2020) (Kg)
Figure 76. Saudi Arabia Vaccine Adjuvants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. U.A.E Vaccine Adjuvants Sales Growth Rate (2015-2020) (Kg)
Figure 78. U.A.E Vaccine Adjuvants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of Vaccine Adjuvants by Type (2015-2020)
Figure 80. Sales Market Share of Vaccine Adjuvants by Type in 2019
Figure 81. Revenue Share of Vaccine Adjuvants by Type (2015-2020)
Figure 82. Revenue Market Share of Vaccine Adjuvants by Type in 2019
Figure 83. Global Vaccine Adjuvants Sales Growth by Type (2015-2020) (Kg)
Figure 84. Global Vaccine Adjuvants Sales Market Share by Application (2015-2020)
Figure 85. Global Vaccine Adjuvants Sales Market Share by Application in 2019
Figure 86. Global Revenue Share of Vaccine Adjuvants by Application (2015-2020)
Figure 87. Global Revenue Share of Vaccine Adjuvants by Application in 2020
Figure 88. SEPPIC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. SDA BIO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Croda International Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. SPI Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Phibro Animal Health Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Tj Kaiwei Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Novavax Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Zhuoyue Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Aphios Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. CSL Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Brenntag Biosector Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. SEPPIC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. SPI Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Novavax Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Avanti Polar Lipids Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Aphios Total Revenue (US$ Million): 2019 Compared with 2018
Figure 105. Price Trend of Key Raw Materials
Figure 106. Manufacturing Cost Structure of Vaccine Adjuvants
Figure 107. Manufacturing Process Analysis of Vaccine Adjuvants
Figure 108. Vaccine Adjuvants Industrial Chain Analysis
Figure 109. Channels of Distribution
Figure 110. Distributors Profiles
Figure 111. Porter's Five Forces Analysis
Figure 112. North America Vaccine Adjuvants Sales (Kg) and Growth Rate Forecast (2021-2026)
Figure 113. North America Vaccine Adjuvants Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Europe Vaccine Adjuvants Sales (Kg) and Growth Rate Forecast (2021-2026)
Figure 115. Europe Vaccine Adjuvants Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Latin America Vaccine Adjuvants Sales (Kg) and Growth Rate Forecast (2021-2026)
Figure 117. Latin America Vaccine Adjuvants Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 118. Middle East and Africa Vaccine Adjuvants Sales (Kg) and Growth Rate Forecast (2021-2026)
Figure 119. Middle East and Africa Vaccine Adjuvants Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 120. Asia Pacific Vaccine Adjuvants Sales (Kg) and Growth Rate Forecast (2021-2026)
Figure 121. Asia Pacific Vaccine Adjuvants Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
  • Global Swine Vaccines Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 08-Jan-2020        Price: US 3480 Onwards        Pages: 134
    Summary Market Overview The global Swine Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.8% in the forecast period of 2020 to 2025 and will expected to reach USD 1527.7 million by 2025, from USD 1314.6 million in 2019. The Swine Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape......
  • Global Pediatrics Hearing Aids Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 08-Jan-2020        Price: US 3480 Onwards        Pages: 102
    Summary Market Overview The global Pediatrics Hearing Aids market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.9% in the forecast period of 2020 to 2025 and will expected to reach USD 2458.5 million by 2025, from USD 1810.9 million in 2019. The Pediatrics Hearing Aids market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, com......
  • Global Rho Associated Protein Kinase 2 Market 2020 by Company, Regions, Type and Application, Forecast to 2025
    Published: 08-Jan-2020        Price: US 3480 Onwards        Pages: 105
    Summary Market Overview The global Rho Associated Protein Kinase 2 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 28.7% in the forecast period of 2020 to 2025 and will expected to reach USD 5 million by 2025, from USD 2 million in 2019. The Rho Associated Protein Kinase 2 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market sha......
  • Global Presbyopia Correction Devices Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 07-Jan-2020        Price: US 3480 Onwards        Pages: 100
    Summary Market Overview The global Presbyopia Correction Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 17.2% in the forecast period of 2020 to 2025 and will expected to reach USD 33 million by 2025, from USD 17 million in 2019. The Presbyopia Correction Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share......
  • Global Tracheotomy Tube Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 07-Jan-2020        Price: US 3480 Onwards        Pages: 109
    Summary Market Overview The global Tracheotomy Tube market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.6% in the forecast period of 2020 to 2025 and will expected to reach USD 197.9 million by 2025, from USD 171.5 million in 2019. The Tracheotomy Tube market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landsca......
  • Global Herbal Medicine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 07-Jan-2020        Price: US 3480 Onwards        Pages: 152
    Summary Market Overview The global Herbal Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.4% in the forecast period of 2020 to 2025 and will expected to reach USD 182530 million by 2025, from USD 142360 million in 2019. The Herbal Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landsca......
  • Global Hepatocyte Growth Factor Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 07-Jan-2020        Price: US 3480 Onwards        Pages: 105
    Summary Market Overview The global Hepatocyte Growth Factor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5% in the forecast period of 2020 to 2025 and will expected to reach USD 61 million by 2025, from USD 49 million in 2019. The Hepatocyte Growth Factor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competiti......
  • Global Surgical Sponge Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 07-Jan-2020        Price: US 3480 Onwards        Pages: 135
    Summary Market Overview The global Surgical Sponge market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.4% in the forecast period of 2020 to 2025 and will expected to reach USD 2526.9 million by 2025, from USD 2206.7 million in 2019. The Surgical Sponge market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landsca......
  • Global Veterinary Vaccine Adjuvants Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 07-Jan-2020        Price: US 3480 Onwards        Pages: 107
    Summary Market Overview The global Veterinary Vaccine Adjuvants market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.2% in the forecast period of 2020 to 2025 and will expected to reach USD 382.2 million by 2025, from USD 300.7 million in 2019. The Veterinary Vaccine Adjuvants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market sh......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs